Biomarker | Biomarker Levels at the Time of Biopsy | ||
---|---|---|---|
Nonresponders | Responders | p* | |
TGF-β | 3.74 ± 0.21 | 2.61 ± 0.22 | < 0.0001 |
Ceruloplasmin | 9.76 ± 0.29 | 8.58 ± 0.30 | 0.006 |
Transferrin | 2.12 ± 0.32 | 0.93 ± 0.34 | 0.012 |
AGP | 11.44 ± 0.36 | 10.24 ± 0.38 | 0.023 |
VDBP | 6.65 ± 0.31 | 5.65 ± 0.32 | 0.027 |
Hepcidin | 6.88 ± 0.60 | 8.70 ± 0.62 | 0.037 |
LPGDS | 6.19 ± 0.31 | 5.30 ± 0.28 | 0.044 |
MCP-1 | 6.87 ± 0.21 | 6.28 ± 0.22 | 0.057 |
NGAL | 3.77 ± 0.22 | 3.20 ± 0.23 | 0.079 |
KIM-1 | 7.37 ± 0.22 | 7.10 ± 0.23 | 0.402 |
Osteopontin | 4.66 ± 0.32 | 4.30 ± 0.34 | 0.432 |
Hemopexin | 8.10 ± 0.25 | 7.82 ± 0.26 | 0.443 |
Cystatin-C | 4.35 ± 0.20 | 4.10 ± 0.26 | 0.451 |
Adiponectin | 10.65 ± 0.36 | 10.27 ± 0.37 | 0.463 |
LFABP | 3.10 ± 0.26 | 3.09 ± 0.31 | 0.975 |
↵* P values are computed using mixed effect models. NGAL: neutrophil gelatinase associated lipocalin; KIM-1: kidney injury molecule 1; MCP-1: monocyte chemotactic protein 1; AGP: α-1-acid glycoprotein; TGF-β: transforming growth factor-β; LFABP: liver-type fatty acid-binding protein 1; VDBP: vitamin D binding protein; LPGDS: lipocalin-like prostaglandin D synthase.